TY - JOUR
T1 - A wellness study of 108 individuals using personal, dense, dynamic data clouds
AU - Price, Nathan D.
AU - Magis, Andrew T.
AU - Earls, John C.
AU - Glusman, Gustavo
AU - Levy, Roie
AU - Lausted, Christopher
AU - McDonald, Daniel T.
AU - Kusebauch, Ulrike
AU - Moss, Christopher L.
AU - Zhou, Yong
AU - Qin, Shizhen
AU - Moritz, Robert L.
AU - Brogaard, Kristin
AU - Omenn, Gilbert S.
AU - Lovejoy, Jennifer C.
AU - Hood, Leroy
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Personal data for 108 individuals were collected during a 9-month period, including whole genome sequences; clinical tests, metabolomes, proteomes, and microbiomes at three time points; and daily activity tracking. Using all of these data, we generated a correlation network that revealed communities of related analytes associated with physiology and disease. Connectivity within analyte communities enabled the identification of known and candidate biomarkers (e.g., gamma-glutamyltyrosine was densely interconnected with clinical analytes for cardiometabolic disease). We calculated polygenic scores from genome-wide association studies (GWAS) for 127 traits and diseases, and used these to discover molecular correlates of polygenic risk (e.g., genetic risk for inflammatory bowel disease was negatively correlated with plasma cystine). Finally, behavioral coaching informed by personal data helped participants to improve clinical biomarkers. Our results show that measurement of personal data clouds over time can improve our understanding of health and disease, including early transitions to disease states.
AB - Personal data for 108 individuals were collected during a 9-month period, including whole genome sequences; clinical tests, metabolomes, proteomes, and microbiomes at three time points; and daily activity tracking. Using all of these data, we generated a correlation network that revealed communities of related analytes associated with physiology and disease. Connectivity within analyte communities enabled the identification of known and candidate biomarkers (e.g., gamma-glutamyltyrosine was densely interconnected with clinical analytes for cardiometabolic disease). We calculated polygenic scores from genome-wide association studies (GWAS) for 127 traits and diseases, and used these to discover molecular correlates of polygenic risk (e.g., genetic risk for inflammatory bowel disease was negatively correlated with plasma cystine). Finally, behavioral coaching informed by personal data helped participants to improve clinical biomarkers. Our results show that measurement of personal data clouds over time can improve our understanding of health and disease, including early transitions to disease states.
UR - http://www.scopus.com/inward/record.url?scp=85027179549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027179549&partnerID=8YFLogxK
U2 - 10.1038/nbt.3870
DO - 10.1038/nbt.3870
M3 - Article
C2 - 28714965
AN - SCOPUS:85027179549
SN - 1087-0156
VL - 35
SP - 747
EP - 756
JO - Nature biotechnology
JF - Nature biotechnology
IS - 8
ER -